Answers are grounded in this paper and cite their sources.
: Atherosclerotic plaque remains a fundamental substrate underlying the occurrence of ischemic events in the current era of cardiovascular care. Understanding pathobiologic contributors to atherosclerosis, targeting treatment pathways, generating high-quality data, and implementing evidence into clinical practice are necessary to improve outcomes among patients with atherosclerotic disease.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: